ReproCELL
4978.TTSE GROWTHChemicals
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥2.2bn | ¥3.0bn | ¥2.4bn | ¥3.0bn | ¥2.2bn | ¥1.3bn |
| Operating income | −¥860m | −¥130m | −¥409m | −¥356m | −¥647m | −¥1.0bn |
| Ordinary income | −¥581m | ¥45m | ¥40m | −¥120m | −¥507m | −¥789m |
| Net income (owners) | −¥592m | ¥103m | −¥31m | −¥305m | −¥575m | −¥813m |
| Total assets | ¥9.7bn | ¥9.7bn | ¥9.1bn | ¥8.4bn | ¥8.1bn | ¥6.0bn |
| Net assets / equity | ¥8.8bn | ¥9.0bn | ¥8.3bn | ¥7.6bn | ¥7.3bn | ¥5.4bn |
| Operating cash flow | −¥384m | ¥6m | −¥11m | −¥141m | −¥246m | −¥649m |
| EPS (basic) | ¥-6.25 | ¥1.11 | ¥-0.37 | ¥-3.62 | ¥-7.57 | ¥-11.38 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 6
| Period | Form | Figures |
|---|---|---|
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 50 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 71 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 47 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 49 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 73 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 47 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales |
|---|---|
| Medical Business | ¥281m |
| Research Support Business | ¥2.0bn |
| Adjustments & eliminations | — |
| Total | ¥2.2bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.